Bnp Paribas Asset Management Holding S.A. Evolus, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Evolus, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 499 shares of EOLS stock, worth $3,243. This represents 0.0% of its overall portfolio holdings.
Number of Shares
499Holding current value
$3,243% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EOLS
# of Institutions
186Shares Held
55.6MCall Options Held
1.21MPut Options Held
48.5K-
Tang Capital Management LLC San Diego, CA5MShares$32.5 Million2.76% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.2MShares$27.3 Million1.69% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$26.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.32MShares$21.6 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.47MShares$16.1 Million1.0% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $365M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...